Skip to content
Abierto

Award notice, first published as combined synopsis and solicitation

VA Tucson Radiopharmaceuticals Base DO

36C26226Q0334

Department of Veterans Affairs, 262-Network Contract Office 22. Pharmaceutical Preparation Manufacturing.

Awarded

RLS (Usa) Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the combined synopsis and solicitation of February 17, 2026.

Solicitation/RFQ 36C26226Q0334 is hereby amended by Amendment 0003 as follows:

Delete the line item: Remove line item – Quadramet from the schedule.

Update Period of Performance: Revise B.2 Statement of Work to reflect that the Period of Performance (PoP) is now Base year plus Two option years. The updated PoP dates are reflected in the revised spreadsheet B.2 Price Cost Schedule – UPDATED v.3. Submission requirement: All previous submissions are hereby rendered invalid.

Interested contractors must submit a new quote that incorporates these changes and acknowledges receipt of amendment 0003. Contractors remain responsible for ensuring all calculations are accurate and maintaining the correct excel form. All other terms and conditions remain unchanged and in full force and effect. See attached document: B.3 Price Cost Schedule - UPDATED v.3.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
UA3GDUKRYSM5
CAGE
8JQE2
Vendor location
Lake Mary, FL
Contract
36C26226D0065
Obligated
$0.00, potential $6,992,473
Actions
3 between February 24, 2026 and May 19, 2026
Competition
Competed Under SAP, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
VA Phoenix and Tucson Radiopharmaceuticals IDIQ
Match
solicitation number 36C26226Q0334 equals the FPDS solicitation identifier; same awarding office 36C262 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 30, 2026

    Combined synopsis and solicitation

    VA Phoenix and Tucson Radiopharmaceuticals IDIQ

    Due February 13, 2026 at 1:00 PM EST. SAM.gov, notice 3498c7d8c166428b8438bc8079adf90e

  2. February 6, 2026

    Combined synopsis and solicitation

    VA Phoenix and Tucson Radiopharmaceuticals IDIQ

    Due February 13, 2026 at 1:00 PM EST. SAM.gov, notice 7a838dacd85b4fdd9631931c121383db

  3. February 10, 2026

    Combined synopsis and solicitation

    VA Phoenix and Tucson Radiopharmaceuticals IDIQ

    Due February 13, 2026 at 1:00 PM EST. SAM.gov, notice 2e522b058b484d2c99da489bb26531e7

  4. February 17, 2026

    Combined synopsis and solicitation

    VA Phoenix and Tucson Radiopharmaceuticals IDIQ

    Due February 20, 2026 at 1:00 PM EST. SAM.gov, notice 50d79a8e27e4410bb706568fba945b29

  5. February 24, 2026

    Award notice, originally combined synopsis and solicitation

    VA Phoenix and Tucson Radiopharmaceuticals IDIQ

    Awarded to RLS (Usa) Inc. Lake Mary 32746 FLK for $6,992,473. SAM.gov, notice 009ee7105b9f4d5abda6da8549c50dd4

  6. March 5, 2026

    Award notice, originally combined synopsis and solicitation

    VA Phoenix Radiopharmaceuticals Base DO

    Awarded to RLS (Usa) Inc. Lake Mary 32746 FLK for $1,561,204. SAM.gov, notice 281a540948ef4acab0709bee18ff1d4e

  7. March 5, 2026

    Award notice, originally combined synopsis and solicitation

    Awarded to RLS (Usa) Inc. Lake Mary 32746 FLK for $752,000. SAM.gov, notice 432cd106ce924251a5ccaab22316f45d

Points of contact